Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions
И. Ф. Беленичев(Zaporizhzhia State Medical and Pharmaceutical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Е. В. Супрун(Institute of Neurology, Psychiatry and Narcology), Nina Bukhtiyarova(Zaporizhzhia State Medical and Pharmaceutical University), Olena Popazova(Zaporizhzhia State Medical and Pharmaceutical University), Valentyn Oksenych(University of Bergen), Victor Ryzhenko(Zaporizhzhia State Medical and Pharmaceutical University), С. В. Павлов(Zaporizhzhia State Medical and Pharmaceutical University)
Cited by 13
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48